Mitochondrial Reactive Oxygen Species: Double-Edged Weapon in Host Defense and Pathological Inflammation During Infection

Mitochondria are inevitable sources for the generation of mitochondrial reactive oxygen species (mtROS) due to their fundamental roles in respiration. mtROS were reported to be bactericidal weapons with an innate effector function during infection. However, the controlled generation of mtROS is vital for the induction of efficient immune responses because excessive production of mtROS with mitochondrial damage leads to sustained inflammation, resulting in pathological outcomes such as sepsis. Here, we discuss the beneficial and detrimental roles of mtROS in the innate immune system during bacterial, viral, and fungal infections. Recent evidence suggests that several pathogens have evolved multiple strategies to modulate mtROS for their own benefit. We are just beginning to understand the mechanisms by which mtROS generation is regulated and how mtROS affect protective and pathological responses during infection. Several agents/small molecules that prevent the uncontrolled production of mtROS are known to be beneficial in the maintenance of tissue homeostasis during sepsis. mtROS-targeted approaches need to be incorporated into preventive and therapeutic strategies against a variety of infections.

Introduction

Mitochondria are essential organelles for the generation of reactive oxygen species (ROS) through respiration and function as a crucial signaling platform for various biological responses, including metabolism, innate immunity, and inflammation (1). Innate immune cells such as macrophages and neutrophils produce and employ mitochondrial reactive oxygen species (mtROS) as direct antimicrobial agents in host defense to combat pathogens (2). Accumulating evidence has revealed more complex molecular functions of mtROS in the activation of nucleoside oligomerization domain-, leucine-rich repeat-, and pyrin domain-containing protein 3 (NLRP3) inflammasomes and the regulation of innate signaling pathways triggered by numerous pattern-recognition receptor engagement (3, 4). Indeed, mtROS are critically required for innate host defense as effectors through their toxic action against pathogens. However, uncontrolled regulation of mtROS may lead to chronic inflammation and pathologies during infection (5, 6).

In this review, we discuss recent advances in our understanding of the protective role of mtROS associated with host-defensive signaling pathways involved in actions against pathogens during infection. We further highlight how pathogens evade mtROS-dependent antimicrobial responses or enhance mtROS-mediated pathological inflammation. In addition, we review the detrimental functions of mtROS when they are produced in excess in damaged cells and tissues during infection. We also introduce the idea that several agents/approaches evolved to modulate mtROS in the maintenance of tissue homeostasis in the context of sepsis. An understanding of the collective actions of mtROS in innate immune functions represents a new frontier in the development of novel therapeutic strategies against acute and chronic infections.

Protective Functions of mtROS in the Activation of the Host Defense

mtROS in Innate Immune Signaling

A decade ago, strong evidence indicated that mtROS provide antimicrobial responses in the context of innate immunity. Numerous studies showed that the maximal bactericidal activity in innate immune cells depended on mtROS generation. Toll-like receptor (TLR; TLRs 1, 2, and 4) signaling triggers the recruitment of mitochondria to the phagosomes and augments mtROS generation to enhance macrophage bactericidal activity (7). Additional studies showed that the mammalian STE20-like protein kinase-1/2 (MST1/2) were required for ROS production through mitochondrial trafficking to the phagosomes, and that they promoted TLR-mediated assembly of the tumor necrosis factor receptor-associated factor 6 (TRAF6), an evolutionarily conserved signaling intermediate in Toll pathway (ECSIT) complex, thus enhancing antibacterial killing and inflammatory signaling in macrophages (7–9). Importantly, ECSIT plays a role in the assembly and activity of respiratory complex-I of the electron transport chain (ETC) to produce mtROS in macrophages after TLR4 stimulation (10). In neutrophils, mtROS mediates the functional responses such as oxidative burst, degranulation and apoptosis (11), as well as NETosis induced by Ca²⁺ ionophore where mitochondrial permeability transition pore (mPTP) is critically involved in mtROS production (12). These studies suggest the role for mtROS in the regulation of different aspects of innate immune responses in macrophages and neutrophils against pathogenic stimuli.

mtROS in Antibacterial and Antiparasitic Defense

Several other studies showed the role of mtROS as the antimicrobial components in the innate defense against bacterial infection. Early studies showed that Th1 cytokine interferon (IFN)-γ signaling activated transcriptional activation of the mitochondrial respiratory chain machinery through the nuclear receptor estrogen-related receptor α (ERRα; NR3B1), which is required for mtROS generation to promote clearance of Listeria monocytogenes (13). A more recent study revealed that ERRα is essentially required for antimicrobial host defense against Mycobacterium tuberculosis (Mtb) infection through autophagy activation, although whether mtROS was implicated in the activation of xenophagy, a selective autophagy-targeting pathogen (14), was not clarified (15). As mtROS play key roles in the maintenance of cellular homeostasis, such as autophagy (16, 17), additional studies are warranted to elucidate the roles of mtROS in the activation of xenophagy in the context of the innate immune defense. Although relatively uncharacterized in the function of mtROS in terms of antiparasitic defense, mtROS contributed to upregulating the intracellular clearance of Leishmania donovani, an intracellular parasite (18, 19).

Although there are some debates, the metabolic sensor 5' AMP-activated protein kinase (AMPK) inhibits the generation of mtROS, whereas hypoxia-inducible factor (HIF)-1α upregulates mtROS production. Mutual regulation between AMPK and HIF-1α is required to maintain mtROS at the optimal level, thereby promoting the innate defense against several pathogenic bacteria (20, 21). HIF-1α and the mammalian target of the rapamycin (mTOR) pathway are critical for driving an immunometabolic signaling toward glycolysis during infection (22, 23). The mTOR-mediated aerobic glycolysis in human monocytes (CD14⁺CD16⁻) results in the accumulation of ROS and inflammatory signaling to activate monocyte function (23). However, mTOR inhibition upregulates mtROS production and NLRP3 inflammasome activation to suppress the replication of Trypanosoma cruzi in macrophages (24). More investigation into the paradoxical function of mTOR signaling is required for a better understanding of its role in the coordination of immunometabolism and mtROS-related host defense. Metformin, a widely used antidiabetic drug, was beneficial in the clearance of Legionella pneumophila infection through AMPK signaling activation and mtROS generation (25). Metformin-mediated antibacterial effects were ameliorated by glutathione treatment, suggesting a protective role of mtROS in improving antibacterial immunity against L. pneumophila pneumonia (25). In addition, it should be noted that ERRα is regulated at the downstream of AMPK to enhance antimycobacterial immunity and plays a crucial role in the activation of autophagy (15). Therefore, a delicate control of immunometabolic shifting between aerobic glycolysis (HIF-1α/mTOR-mediated) and mitochondrial respiration (AMPK mediated) may affect the innate effector functions, at least partly through the regulation of mtROS generation.

Moreover, macrophage recognition of live bacteria led to a transient shift in the mitochondrial respiratory system and destabilization of the ETC complex I but increased the activity of complex II, which was essential for the antimicrobial response (26). During live bacterial sensing in macrophages, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-mediated ROS, in cooperation with mtROS, play essential roles in the early induction of ETC adaptations (26). In this regard, mtROS, which are derived from several respiratory complexes (complexes I, II, and III) (27, 28), may contribute to the different aspects of antimicrobial and inflammatory function, and further investigation of their specific roles depending on differential sources and cell types is warranted.

mtROS in Antiviral Signaling

Early studies highlighted the function of mtROS in the amplification of mitochondrial antiviral signaling (MAVS) and RIG-I-like receptor (RLR)-mediated antiviral responses (29). During infection with influenza A virus (IAV), both mitochondrial and dual oxidase (Doux) 2-generated ROS were essential for the antiviral host defense in normal human nasal epithelial (NHNE) cells. Notably, the induction of the IFN-λ gene and protein expression, which was mediated through ROS, contributed to the suppression of IAV viral titers (30). Another study showed that mtROS generation was required for IAV-induced signal transducer and activator of transcription (STAT) phosphorylation and IFN-stimulated gene expression, which promoted antiviral responses in NHNE cells (31). Scavenging mtROS led to the attenuation of innate immune responses to IAV and increased viral titers in nasal epithelial cells (30, 31). These findings suggest that mtROS play a crucial role in the induction of antiviral immune defense against IAV infection.

A recent study identified tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP ribose) polymerase (TIPARP), a zinc finger antiviral protein (ZAP), as a pattern-recognition receptor for the RNA of Sindbis virus (32), a positive-sense single-stranded RNA virus belonging to the genus Alphavirus in the family Togaviridae (33). TIPARP was found to protect mice against lethal Sindbis virus infection through promotion of antiviral responses. It was noted that TIPARP redistribution from the nucleus to the cytoplasm during infection is mediated through mtROS-dependent oxidization of the nuclear pore and mitochondrial damage (32). This cytoplasmic accumulation of TIPARP, which is triggered by mtROS, seems to favor the persistence of TIPARP localization in the cytosol to mediate antiviral response in the host cells (32). In addition to TIPARP, there are several zinc finger domain-containing protein family members that participate in the inhibition of viral replication, particularly in HIV-1 and flavivirus infections (34, 35). The role of mtROS in most zinc finger domain-containing family members should be characterized in a future study.

mtROS also cooperate with several innate effectors/pathways in macrophages and/or other immune cells during infection. mtROS participate in the activation of the NLRP3 inflammasome, which plays a crucial function in the innate immune defense against numerous pathogens (3, 4). Indeed, mtROS activation serves as an important second signal to trigger NLRP3 inflammasome activation, which leads not only to the host defense against diverse bacterial, viral, and fungal infections but also to pathophysiological responses when uncontrolled or dysregulated (3). Elucidating the potential mechanisms of the coordinated mtROS generation could help develop further knowledge on host defense through appropriate activation of NLRP3 inflammasome complex during infections by various pathogens.

Autophagy, an intracellular homeostatic process during stress conditions (14), contributes to regulating the production of mtROS during viral infection. Previous studies showed that mtROS generation, accompanied by dysfunctional mitochondria, was upregulated to promote RLR-mediated mitochondrial antiviral signaling protein (MAVS/IPS-1) signaling and resistance to vesicular stomatitis virus infection in ATG5-deficient primary mouse embryonic fibroblasts (MEF) cells and macrophages (29). During Sendai virus infection, mitochondrial COX5B, the ETS component of the cytochrome c oxidase complex subunit, can interact with MAVS and ATG5 and contributes to the balance in MAVS-mediated antiviral signaling (36). Mechanistically, MAVS activation results in the expression of COX5B, which, in turn, downregulates MAVS-mediated antiviral signaling through the inhibition of mtROS. These data suggest a link between the mitochondrial ETS system and MAVS-mediated antiviral signaling through the modulation of ROS (36). A recent study also showed that Parkin, a key player in mitophagy, plays an inhibitory role in antiviral immunity through controlling the mtROS-NLRP3 inflammasome during viral infection. Parkin deficiency amplifies antiviral inflammation by enhancing mtROS to activate the NLRP3 inflammasome, thereby enhancing viral clearance in macrophages and dendritic cells (37). Taken together, these studies highlight the role of mtROS in the balanced regulation of the autophagy–inflammasome axis, which is crucial for the innate host defense. The protective roles of mtROS in antimicrobial innate immune defense are summarized in Figure 1A.

FIGURE 1

Figure 1. Protective and detrimental roles of mitochondrial reactive oxygen species (mtROS) during infection. (A) Majority of mtROS are generated by oxidative phosphorylation (OXPHOS) complexes I and III in macrophages activated through TLR signaling, interferon (IFN)-γ, and microbial infection. Both Mst1 and Mst2 promoted Toll-like receptor (TLR)-mediated assembly of the tumor necrosis factor receptor-associated factor 6–evolutionarily conserved signaling intermediate in Toll pathway (TRAF6-ECSIT) complex, to enhance antibacterial killing effects through mtROS. IFN-γ signaling activates estrogen-related receptor α (ERRα) to enhance antimicrobial clearance through mtROS generation. mtROS are closely related to the pathways of autophagy and inflammasome, both essential in the maintenance of cellular homeostasis and activation of innate host defense. 5′ AMP-activated protein kinase (AMPK) inhibits, but hypoxia-inducible factor (HIF)-1α enhances, the generation of mtROS, thereby influencing innate defense against several pathogenic bacteria. HIF-1α/mTOR signaling drives aerobic glycolysis and reactive oxygen species (ROS) generation; mTOR inhibition leads to the enhancement of mtROS to promote host defense against Trypanosoma cruzi infection. AMPK activation by metformin is beneficial in the clearance of intracellular bacterial infection through phosphorylation of AMPK and mtROS generation. In addition, AMPK is the upstream kinase for ERRα-mediated antimicrobial responses during Mycobacterium tuberculosis (Mtb) infection. During oxidative stress, NRF2 translocates to the nucleus after dissociation from Keap1 to induce the expression of protective antioxidant genes. Mitochondrial antiviral signaling (MAVS) activation results in the expression of COX5B, which inhibit the mtROS to block the MAVS-mediated antiviral signaling. mtROS involvement in antiviral responses is described in the text in details. (B) Uncontrolled mtROS production leads to excessive inflammatory responses, tissue damage, and necrosis, thus detrimental to host defense. Dysregulated activation of NLRP3 inflammasome results in tissue damage and pathological inflammation through mitochondrial dysfunction and mtROS generation. Several host factors [sirtuin 3 (SIRT3), miR-23a, and peroxisome proliferator-activated receptor gamma (PPARγ)] are negative regulators for controlling excessive mtROS generation, thereby coordinating antimicrobial host defense. Excessive ROS production blocks the nuclear translocation and activity of NRF2. The accumulation of mtROS, which is also mediated by sustained endoplasmic reticulum (ER) stress, is detrimental to host defense.

Pathogens Modulate mtROS to Promote Pathogenesis and Virulence

Bacteria, Fungi, and Parasites Regulate Host mtROS for Their Own Benefits

Several studies showed that pathogens and their components are able to evade host immune system or augment pathological inflammation through modulation of mitochondrial oxidative stresses for their own benefits. A recent study showed that the outer membrane protein 34 (Omp34) of Acinetobacter baumannii, a Gram-negative opportunistic pathogen, triggers mtROS generation, leading to the hyper-activation of NLRP3 inflammasome and pyroptosis during infection (38). In addition, Escherichia coli O157:H7 can induce severe inflammation through damage of mitochondria and mtROS, which triggered NLRP3 inflammasome activation; this was ameliorated by quercetin via prevention of ROS and autophagy activation (39). Moreover, Aspergillus protease stimulation of lung epithelial cells (A549 cells) upregulated mRNAs of a variety of inflammatory cytokines and intercellular adhesion molecule (ICAM)-1 through mtROS (40), suggesting the role of mtROS as a therapeutic target for fungal inflammation.

In Pseudomonas aeruginosa infection, pyocyanin is an important virulence factor through which mtROS mediate cell apoptosis through the induction of mitochondrial acid sphingomyelinase in neutrophils (41). In addition, pyocyanin can trigger natural killer (NK) cell apoptosis through mitochondrial damage and intracellular calcium release (42). Although the exact role for mtROS was not described in this study, intracellular ROS, generated by the NADPH oxidase, was not involved in NK cell death (42). As mitochondrial damage results in the excessive mtROS production in numerous pathological conditions (43), future studies will clarify the role for mtROS in immune cell death during P. aeruginosa infection.

Early studies showed that the intracellular parasite Leishmania donovani targets and stabilizes host transcriptional factor SREBP2 to regulate macrophage cholesterol and inhibit microbicidal mtROS production, thereby favoring parasite persistence (18). In another study, L. donovani infection induced the upregulation of uncoupling protein 2 (UCP2) to inhibit mtROS generation, thereby attenuating host Th1-biased immune response and parasitic clearance (19). These data support the idea that several pathogens may alter the host gene program and/or immune metabolism to up- or downregulate mtROS production, thereby inhibiting host cell death and/or facilitating parasite survival.

Bacterial pathogens can also inhibit potentially harmful oxidative radicals for their own survival. In human gingival epithelial cells, Porphyromonas gingivalis can circumvent the hypochlorous acid (HOCl)-mediated antimicrobial clearance system through the activation of host glutathione synthesis pathways (44). Porphyromonas gingivalis nucleoside-diphosphate kinase (Ndk) was found to act as an effector, inhibiting antimicrobial signaling activities by extracellular adenosine triphosphate-induced ROS production, thus leading to pathogen persistence in gingival epithelial cells (45). Overall, the data suggest that several microbial pathogens evade or inhibit the host-defensive mtROS pathway and bactericidal free radicals (Table 1). Future experimental data are needed to elucidate the mechanisms by which each pathogen modulates the components/pathways of the host mtROS production system.

TABLE 1

Table 1. Pathogen-mediated modulation of mtROS.

Viruses Manipulate Host mtROS for Pathogenesis

Numerous viruses co-opt host mitochondrial functions and mtROS to favor their pathogenesis and virulence (Table 1). A recent study showed that respiratory syncytial virus infection resulted in the impairment of mitochondrial respiration, loss of mitochondrial membrane potential, and increased mtROS, which promoted and favored viral replication in the cells (47). In addition, human immunodeficiency virus (HIV) can suppress or enhance mtROS generation in both productive and non-productive stages for its own benefit. Productive HIV infection in human astrocytes led to the attenuation of mtROS production and dissipation of matrix metalloproteinases, thereby making the virus resistant to cell death, whereas non-productive HIV infection induced mitochondrial damage and inflammasome-induced cell death (48). Mechanistically, productive HIV infection increased the mitophagy to resist cell death, whereas non-productive HIV infection enhanced the pyroptosis of astrocytes through NLRP3-mediated gasdermin D pathway activation (48). Thus, HIV co-opts mtROS and mitochondrial damage in both productive and non-productive infection to drive viral pathogenesis in HIV-associated neurodegenerative diseases (48). In addition, IAV can also circumvent antiviral responses and favor viral replication through NADPH oxidase 2-mediated endogenous ROS generation (50–52). Additional studies are warranted to reveal how a variety of viruses manipulate mtROS in relation to pathological inflammation, thereby enhancing their virulence and pathogenesis.

Detrimental Roles of mtROS During Infection and Sepsis

mtROS in the Amplification of Pathological Responses During Infection

Uncontrolled ROS production is thought to lead to necrosis, thereby resulting in hyper-inflammation and tissue damage (53). Tumor necrosis factor (TNF) is an essential cytokine for the maintenance of host defense during human tuberculosis (TB), as patients with rheumatoid arthritis often develop TB reactivation during anti-TNF therapy (54). In the pathogenesis of TB, mtROS production due to hyper-TNF responses plays a detrimental role, inducing host cell-programmed necrosis and the propagation of mycobacteria into the extracellular milieu (54). In a recent study, sirtuin 3 was shown to be critically involved in the host defense against Mtb infection through the control of exaggerated proinflammatory responses and neutrophil infiltration (55). These protective effects were mediated through the sirtuin 3-dependent inhibition of mitochondrial dysfunction and excessive mtROS generation in macrophages during Mtb infection (55). During infection with E. coli O157:H7, a pathogen that causes serious gastrointestinal infection, mitochondrial dysfunction and oxidative stress were associated with excessive inflammation and host damage (39). In addition, exaggerated production of mtROS results in fungus-mediated pathological inflammation in airway epithelial cells (40) and T. cruzi-mediated cardiomyopathy in Chagas disease (46). Also, mtROS inhibition suppressed respiratory syncytial virus replication and virus-mediated lung inflammation (47). These data suggest the pathogenic role of mtROS during infections of various pathogens.

As mtROS affect the number of phagocytes during infection, blockade of mtROS or superoxide dismutase functions in beneficial roles through the prevention of cell death in several severe infections. Previous studies showed that either Sod2 deficiency or MitoTEMPO, a scavenger of mtROS, treatment increased neutrophil numbers and reduced the bacterial burden during P. aeruginosa infection in zebrafish models (56). Moreover, recent studies showed that IAV-mediated exacerbation of viral pathogenesis is ameliorated by scavenging mitoROS (49). During IAV infection, the local delivery of MitoTEMPO significantly inhibited viral titers and mortality in mice infected with IAV (Hkx31, H3N2) and attenuated apoptotic and necrotic neutrophils/macrophages in lung tissues during infection (49). These data suggest the pathological effects of mtROS that promote harmful inflammation and cell death during severe pathogenic infection and support the potential use of mtROS scavengers as host-directed adjuvant therapies.

Host Factors and Mechanisms That Ameliorate mtROS Generation During Infection

There are several reports suggesting the mechanisms by which mtROS generation is controlled in the host cells during infection. Previous studies have shown that microRNA-23a is essential for the maintenance of mitochondrial integrity and restriction of mtROS through the targeting of PPIF, the gatekeeper of mitochondria permeability transition pores, thereby blocking excessive necrosis and liver damage in L. monocytogenes infection (53). In rotavirus infection, the accumulation of mtROS is mediated by sustained endoplasmic reticulum (ER) stress and the release of calcium from the ER to the mitochondria, which further contributes to viral inflammation (57). Furthermore, the inhibition of mtROS, at least partly through peroxisome proliferator-activated receptor gamma (PPARγ) activation, played a beneficial role in the reduction of rotavirus infection (58). These data encourage us to target mtROS as a therapeutic strategy for viral infections by alleviation of virus-mediated ER stress and inflammatory responses (57, 58).

There is emerging interest in the role of nuclear factor erythroid 2-related factor 2 (NFE2L2)/Nrf2, a master regulator of antioxidant and anti-apoptosis system (59, 60), in the regulation of mitochondrial homeostatic functions in a variety of physiological and pathological conditions including infection (60, 61). During P. aeruginosa infection, the non-histone nuclear protein HMGN2 contributes to the cell-autonomous immune defense through the clearance of pyocyanin-mediated intracellular oxidative stress via elevation of the Nrf2-mediated antioxidant gene (62). In T. cruzi infection, mtROS production was increased in vivo and in vitro, resulting in the inhibition of nuclear translocation of Nrf2 and antioxidant gene expression (46). Preserving Nrf2 activity was beneficial for maintenance of cardiac function in heart failure of infectious etiologies (46). Together, these findings highlight the mechanisms by which mtROS accumulation and mitochondrial damage are mediated, although a large body of mechanism has not been well-defined, in a variety of infections. The actions of known host factors to regulate mtROS in the context of infection are illustrated in Figure 1.

Detrimental Roles of mtROS During Sepsis

Relatively well-characterized functions of mtROS generation have been shown in the human and animal model of sepsis. In patients with sepsis, mitochondrial function and antioxidant defenses appear to have important roles in the protection against multi-organ failure through the control of harmful excessive ROS production (63, 64). In sepsis-induced acute kidney injury, mitochondrial alteration and ROS production contributed to pathology, which was ameliorated by SIRT3, a NAD(+)-dependent deacetylase (65). In a study, mesenchymal stromal cells showed beneficial effects on experimental sepsis through the inhibition of macrophage NLRP3 inflammasome activation via suppression of mtROS (66). A recent genetic study showed that a specific mtDNA mutation (T6459C) might be associated with genetic susceptibility to sepsis, as the mutation group showed increased ROS levels and apoptosis (67). GABA type A receptor-associated protein (GABARAP) deficiency led to increased susceptibility to sepsis through the enhancement of mtROS and proinflammatory cytokine expression with NLRP3 inflammasome activation (68). Furthermore, blockade of the NOTCH pathway inhibited mtROS generation through the suppression of glucose oxidation, thereby attenuating hepatic macrophage M1 shifting, which reduced the lethality of endotoxin-mediated fulminant hepatitis (69). These data suggest that understanding the molecular mechanisms by which host factors target mtROS generation can contribute to the development of potential therapeutic strategies against sepsis.

Given the role of mtROS in the pathogenesis of sepsis, targeted delivery of antioxidants to mitochondria has been suggested as a potential therapeutic strategy against sepsis (63). Glucocorticoids, which are widely used anti-inflammatory drugs, control endotoxin-mediated inflammation and sepsis by inhibiting mitochondrial calcium homeostasis and the production of mtROS (70). Stefin B, an endogenous cysteine cathepsin inhibitor, was found to be essential for the control of LPS-induced sepsis through the stabilization of mitochondrial membrane potential and amelioration of mtROS generation (71). In a cecal ligation and puncture mouse model of sepsis, synthetic antioxidant lignan secoisolariciresinol diglucoside (SDG; LGM2605) alleviated septic cardiac dysfunction. Mechanistically, LGM2605 improved cardiac function by protecting cardiac mitochondrial function and inhibiting ROS accumulation (72). Furthermore, maresin 1, a metabolite of the omega-3 fatty acid, had significant inhibitory effects on mtROS generation but increased ATP content and the mtDNA copy number, thereby showing a protective role against sepsis (73). Taken together, these data suggest that the agents and small molecules involved in the control of mitochondrial dysfunction could attenuate pathological responses during sepsis through the amelioration of mtROS. Future studies for the pharmacological approaches targeting mtROS may develop potentially promising strategies to increase survival and treatment efficacy of sepsis.

Conclusion

The past several years have provided us with increasing evidence of the means by which the mtROS signaling pathway affects innate immunity during infection. mtROS generation via pathogen infection may bring together the intracellular autophagy, immune, and metabolic pathways to guide and shape the effector response. mtROS-mediated antiviral signaling is linked partially to MAVS and STAT signaling, leading to the antiviral host defense. In addition, mtROS is a crucial signal for bactericidal responses and NLRP3 inflammasome activation to enhance antibacterial responses. Nevertheless, our current knowledge is limited on how mtROS activates antibacterial or antiviral responses, and how mtROS are implicated in the inflammatory signaling pathways under different pathogenic stimuli. Further studies to understand molecular mechanisms will shed new light on the impacts of the mtROS signaling network on distinct innate effector functions and/or for driving pathological inflammatory responses during infection.

Moreover, a variety of pathogens modulate, escape, or enhance mtROS production for their own benefit, although our understanding of the underlying mechanisms remains limited. In the future, elucidating how pathogens interact with host-defensive machineries of mtROS system should help to assess the pathogenesis and/or defensive pathways in the context of infection. As mtROS generation is interconnected with the immunometabolic status in macrophages, it would be extremely interesting to investigate how mtROS crosstalk with the AMPK-mTOR pathway during infection. Further exploiting the host-defensive mechanisms for repressing pathological mtROS production and function is a crucial next step in developing therapeutic application. Although accumulating data have provided extensive evidence that mtROS contribute to inflammation-induced pathology during sepsis, therapeutic outcomes have been limited in the use of mtROS modulators in clinical settings.

Many of the yin-and-yang aspects of mtROS signaling remain unknown in terms of infection. Answers to the above questions will provide exciting new opportunities for therapeutic approaches to many diverse infections.

Author Contributions

E-KJ: designed. E-KJ, PS, JK, and YK wrote and reviewed the manuscript. PS: summarized the table. JK and YK prepared the figure. All authors read and approved the final version of the review.

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (Grand nos. 2017R1A5A2015385 and 2019R1A2C1087686), under the framework of international cooperation program managed by National Research Foundation of Korea (Grant no. 2015K2A2A6002008), and by Chungnam National University Hospital Research Fund, 2019.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We are indebted to current and past members of our laboratory for discussions and investigations that contributed to this article. We thank H-W Suh for critical reading of the paper.

References

1. Sandhir R, Halder A, Sunkaria A. Mitochondria as a centrally positioned hub in the innate immune response. Biochim Biophys Acta Mol Basis Dis. (2017) 1863:1090–7. doi: 10.1016/j.bbadis.2016.10.020

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Stocks CJ, Schembri MA, Sweet MJ, Kapetanovic R. For when bacterial infections persist: toll-like receptor-inducible direct antimicrobial pathways in macrophages. J Leukoc Biol. (2018) 103:35–51. doi: 10.1002/JLB.4RI0917-358R

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Abais JM, Xia M, Zhang Y, Boini KM, Li PL. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal. (2015) 22:1111–29. doi: 10.1089/ars.2014.5994

CrossRef Full Text | Google Scholar

4. Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol. (2014) 5:352. doi: 10.3389/fphys.2014.00352

PubMed Abstract | CrossRef Full Text | Google Scholar

5. To EE, O'Leary JJ, O'Neill LAJ, Vlahos R, Bozinovski S, Porter CJH, et al. Spatial properties of reactive oxygen species govern pathogen-specific immune system responses. Antioxid Redox Signal. (2020) 32:982–92. doi: 10.1089/ars.2020.8027

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Chen Y, Zhou Z, Min W. Mitochondria, oxidative stress and innate immunity. Front Physiol. (2018) 9:1487. doi: 10.3389/fphys.2018.01487

PubMed Abstract | CrossRef Full Text | Google Scholar

7. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. (2011) 472:476–80. doi: 10.1038/nature09973

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Geng J, Sun X, Wang P, Zhang S, Wang X, Wu H, et al. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat Immunol. (2015) 16:1142–52. doi: 10.1038/ni.3268

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Wi SM, Moon G, Kim J, Kim ST, Shim JH, Chun E, et al. TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-kappaB. J Biol Chem. (2014) 289:35205–14. doi: 10.1074/jbc.M114.597187

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Carneiro FRG, Lepelley A, Seeley JJ, Hayden MS, Ghosh S. An essential role for ECSIT in mitochondrial complex I assembly and mitophagy in macrophages. Cell Rep. (2018) 22:2654–66. doi: 10.1016/j.celrep.2018.02.051

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Vorobjeva N, Prikhodko A, Galkin I, Pletjushkina O, Zinovkin R, Sud'ina G, et al. Mitochondrial reactive oxygen species are involved in chemoattractant-induced oxidative burst and degranulation of human neutrophils in vitro. Eur J Cell Biol. (2017) 96:254–65. doi: 10.1016/j.ejcb.2017.03.003

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Vorobjeva N, Galkin I, Pletjushkina O, Golyshev S, Zinovkin R, Prikhodko A, et al. Mitochondrial permeability transition pore is involved in oxidative burst and NETosis of human neutrophils. Biochim Biophys Acta Mol Basis Dis. (2020) 1866:165664. doi: 10.1016/j.bbadis.2020.165664

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Sonoda J, Laganiere J, Mehl IR, Barish GD, Chong LW, Li X, et al. Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense. Genes Dev. (2007) 21:1909–20. doi: 10.1101/gad.1553007

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. (2018) 14:207–15. doi: 10.1080/15548627.2017.1378838

CrossRef Full Text | Google Scholar

15. Kim SY, Yang CS, Lee HM, Kim JK, Kim YS, Kim YR, et al. ESRRA (estrogen-related receptor alpha) is a key coordinator of transcriptional and post-translational activation of autophagy to promote innate host defense. Autophagy. (2018) 14:152–68. doi: 10.1080/15548627.2017.1339001

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. (2007) 17:422–7. doi: 10.1016/j.tcb.2007.07.009

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Roca-Agujetas V, de Dios C, Leston L, Mari M, Morales A, Colell A. Recent insights into the mitochondrial role in autophagy and its regulation by oxidative stress. Oxid Med Cell Longev. (2019) 2019:3809308. doi: 10.1155/2019/3809308

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Mukherjee M, Basu Ball W, Das PK. Leishmania donovani activates SREBP2 to modulate macrophage membrane cholesterol and mitochondrial oxidants for establishment of infection. Int J Biochem Cell Biol. (2014) 55:196–208. doi: 10.1016/j.biocel.2014.08.019

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Basu Ball W, Kar S, Mukherjee M, Chande AG, Mukhopadhyaya R, Das PK. Uncoupling protein 2 negatively regulates mitochondrial reactive oxygen species generation and induces phosphatase-mediated anti-inflammatory response in experimental visceral leishmaniasis. J Immunol. (2011) 187:1322–32. doi: 10.4049/jimmunol.1004237

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Hwang AB, Ryu EA, Artan M, Chang HW, Kabir MH, Nam HJ, et al. Feedback regulation via AMPK and HIF-1 mediates ROS-dependent longevity in Caenorhabditis elegans. Proc Natl Acad Sci USA. (2014) 111:E4458–67. doi: 10.1073/pnas.1411199111

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Kwon S, Kim EJE, Lee SV. Mitochondria-mediated defense mechanisms against pathogens in Caenorhabditis elegans. BMB Rep. (2018) 51:274–9. doi: 10.5483/BMBRep.2018.51.6.111

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Goncalves SM, Duarte-Oliveira C, Campos CF, Aimanianda V, Ter Horst R, Leite L, et al. Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity. Nat Commun. (2020) 11:2282. doi: 10.1038/s41467-020-16120-z

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Lee MKS, Al-Sharea A, Shihata WA, Bertuzzo Veiga C, Cooney OD, Fleetwood AJ, et al. Glycolysis is required for LPS-induced activation and adhesion of human CD14(+)CD16(-) monocytes. Front Immunol. (2019) 10:2054. doi: 10.3389/fimmu.2019.02054

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Rojas Marquez JD, Ana Y, Baigorri RE, Stempin CC, Cerban FM. Mammalian target of rapamycin inhibition in Trypanosoma cruzi-infected macrophages leads to an intracellular profile that is detrimental for infection. Front Immunol. (2018) 9:313. doi: 10.3389/fimmu.2018.00313

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Kajiwara C, Kusaka Y, Kimura S, Yamaguchi T, Nanjo Y, Ishii Y, et al. Metformin mediates protection against Legionella pneumonia through activation of AMPK and mitochondrial reactive oxygen species. J Immunol. (2018) 200:623–31. doi: 10.4049/jimmunol.1700474

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Garaude J, Acin-Perez R, Martinez-Cano S, Enamorado M, Ugolini M, Nistal-Villan E, et al. Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense. Nat Immunol. (2016) 17:1037–45. doi: 10.1038/ni.3509

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Scialo F, Fernandez-Ayala DJ, Sanz A. Role of mitochondrial reverse electron transport in ROS signaling: potential roles in health and disease. Front Physiol. (2017) 8:428. doi: 10.3389/fphys.2017.00428

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. (2012) 48:158–67. doi: 10.1016/j.molcel.2012.09.025

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA. (2009) 106:2770–5. doi: 10.1073/pnas.0807694106

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Kim HJ, Kim CH, Ryu JH, Kim MJ, Park CY, Lee JM, et al. Reactive oxygen species induce antiviral innate immune response through IFN-lambda regulation in human nasal epithelial cells. Am J Respir Cell Mol Biol. (2013) 49:855–65. doi: 10.1165/rcmb.2013-0003OC

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Kim S, Kim MJ, Park DY, Chung HJ, Kim CH, Yoon JH, et al. Mitochondrial reactive oxygen species modulate innate immune response to influenza A virus in human nasal epithelium. Antiviral Res. (2015) 119:78–83. doi: 10.1016/j.antiviral.2015.04.011

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Kozaki T, Komano J, Kanbayashi D, Takahama M, Misawa T, Satoh T, et al. Mitochondrial damage elicits a TCDD-inducible poly(ADP-ribose) polymerase-mediated antiviral response. Proc Natl Acad Sci USA. (2017) 114:2681–6. doi: 10.1073/pnas.1621508114

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Jose J, Snyder JE, Kuhn RJ. A structural and functional perspective of alphavirus replication and assembly. Future Microbiol. (2009) 4:837–56. doi: 10.2217/fmb.09.59

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Maeda M, Sawa H, Tobiume M, Tokunaga K, Hasegawa H, Ichinohe T, et al. Tristetraprolin inhibits HIV-1 production by binding to genomic RNA. Microbes Infect. (2006) 8:2647–56. doi: 10.1016/j.micinf.2006.07.010

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Lin RJ, Chien HL, Lin SY, Chang BL, Yu HP, Tang WC, et al. MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucleic Acids Res. (2013) 41:3314–26. doi: 10.1093/nar/gkt019

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Zhao Y, Sun X, Nie X, Sun L, Tang TS, Chen D, et al. COX5B regulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS production. PLoS Pathog. (2012) 8:e1003086. doi: 10.1371/journal.ppat.1003086

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Li J, Ma C, Long F, Yang D, Liu X, Hu Y, et al. Parkin impairs antiviral immunity by suppressing the mitochondrial reactive oxygen species-Nlrp3 axis and antiviral inflammation. iScience. (2019) 16:468–84. doi: 10.1016/j.isci.2019.06.008

PubMed Abstract | CrossRef Full Text | Google Scholar

38. An Z, Su J. Acinetobacter baumannii outer membrane protein 34 elicits NLRP3 inflammasome activation via mitochondria-derived reactive oxygen species in RAW264.7 macrophages. Microbes Infect. (2019) 21:143–53. doi: 10.1016/j.micinf.2018.10.005

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Xue Y, Du M, Zhu MJ. Quercetin suppresses NLRP3 inflammasome activation in epithelial cells triggered by Escherichia coli O157:H7. Free Radic Biol Med. (2017) 108:760–9. doi: 10.1016/j.freeradbiomed.2017.05.003

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Kim YH, Lee SH. Mitochondrial reactive oxygen species regulate fungal protease-induced inflammatory responses. Toxicology. (2017) 378:86–94. doi: 10.1016/j.tox.2017.01.008

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Manago A, Becker KA, Carpinteiro A, Wilker B, Soddemann M, Seitz AP, et al. Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxid Redox Signal. (2015) 22:1097–110. doi: 10.1089/ars.2014.5979

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Li T, Huang X, Yuan Z, Wang L, Chen M, Su F, et al. Pyocyanin induces NK92 cell apoptosis via mitochondrial damage and elevated intracellular Ca(2). Innate Immun. (2019) 25:3–12. doi: 10.1177/1753425918809860

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. (2014) 94:909–50. doi: 10.1152/physrev.00026.2013

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Roberts JS, Atanasova KR, Lee J, Diamond G, Deguzman J, Hee Choi C, et al. Opportunistic pathogen Porphyromonas gingivalis modulates danger signal ATP-mediated antibacterial NOX2 pathways in primary epithelial cells. Front Cell Infect Microbiol. (2017) 7:291. doi: 10.3389/fcimb.2017.00291

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Choi CH, Spooner R, DeGuzman J, Koutouzis T, Ojcius DM, Yilmaz O. Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits ATP-induced reactive-oxygen-species via P2X7 receptor/NADPH-oxidase signalling and contributes to persistence. Cell Microbiol. (2013) 15:961–76. doi: 10.1111/cmi.12089

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Wen JJ, Porter C, Garg NJ. Inhibition of NFE2L2-antioxidant response element pathway by mitochondrial reactive oxygen species contributes to development of cardiomyopathy and left ventricular dysfunction in chagas disease. Antioxid Redox Signal. (2017) 27:550–66. doi: 10.1089/ars.2016.6831

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Hu M, Schulze KE, Ghildyal R, Henstridge DC, Kolanowski JL, New EJ, et al. Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production. Elife. (2019) 8:e42448. doi: 10.7554/eLife.42448

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Ojeda DS, Grasso D, Urquiza J, Till A, Vaccaro MI, Quarleri J. Cell death is counteracted by mitophagy in hiv-productively infected astrocytes but is promoted by inflammasome activation among non-productively infected cells. Front Immunol. (2018) 9:2633. doi: 10.3389/fimmu.2018.02633

PubMed Abstract | CrossRef Full Text | Google Scholar

49. To EE, Erlich JR, Liong F, Luong R, Liong S, Esaq F, et al. Mitochondrial reactive oxygen species contribute to pathological inflammation during influenza A virus infection in mice. Antioxid Redox Signal. (2020) 32:929–42. doi: 10.1089/ars.2019.7727

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Erlich JR, To EE, Liong S, Brooks R, Vlahos R, O'Leary JJ, et al. Targeting evolutionary conserved oxidative stress and immunometabolic pathways for the treatment of respiratory infectious diseases. Antioxid Redox Signal. (2020) 32:993–1013. doi: 10.1089/ars.2020.8028

PubMed Abstract | CrossRef Full Text | Google Scholar

51. To EE, Vlahos R, Luong R, Halls ML, Reading PC, King PT, et al. Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. Nat Commun. (2017) 8:69. doi: 10.1038/s41467-017-00057-x

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR, Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. (2011) 7:e1001271. doi: 10.1371/journal.ppat.1001271

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Zhang B, Liu SQ, Li C, Lykken E, Jiang S, Wong E, et al. MicroRNA-23a curbs necrosis during early T cell activation by enforcing intracellular reactive oxygen species equilibrium. Immunity. (2016) 44:568–81. doi: 10.1016/j.immuni.2016.01.007

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Roca FJ, Ramakrishnan L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell. (2013) 153:521–34. doi: 10.1016/j.cell.2013.03.022

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Kim TS, Jin YB, Kim YS, Kim S, Kim JK, Lee HM, et al. SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions. Autophagy. (2019) 15:1356–75. doi: 10.1080/15548627.2019.1582743

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Peterman EM, Sullivan C, Goody MF, Rodriguez-Nunez I, Yoder JA, Kim CH. Neutralization of mitochondrial superoxide by superoxide dismutase 2 promotes bacterial clearance and regulates phagocyte numbers in zebrafish. Infect Immun. (2015) 83:430–40. doi: 10.1128/IAI.02245-14

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Guerrero CA, Acosta O. Inflammatory and oxidative stress in rotavirus infection. World J Virol. (2016) 5:38–62. doi: 10.5501/wjv.v5.i2.38

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Gomez D, Munoz N, Guerrero R, Acosta O, Guerrero CA. PPARgamma agonists as an anti-inflammatory treatment inhibiting rotavirus infection of small intestinal villi. PPAR Res. (2016) 2016:4049373. doi: 10.1155/2016/4049373

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. (2004) 24:7130–9. doi: 10.1128/MCB.24.16.7130-7139.2004

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Kasai S, Shimizu S, Tatara Y, Mimura J, Itoh K. Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules. (2020) 10:320. doi: 10.3390/biom10020320

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Soares MP, Ribeiro AM. Nrf2 as a master regulator of tissue damage control and disease tolerance to infection. Biochem Soc Trans. (2015) 43:663–8. doi: 10.1042/BST20150054

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Liu K, Wang X, Sha K, Zhang F, Xiong F, Wang X, et al. Nuclear protein HMGN2 attenuates pyocyanin-induced oxidative stress via Nrf2 signaling and inhibits Pseudomonas aeruginosa internalization in A549 cells. Free Radic Biol Med. (2017) 108:404–17. doi: 10.1016/j.freeradbiomed.2017.04.007

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Rocha M, Herance R, Rovira S, Hernandez-Mijares A, Victor VM. Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets. (2012) 12:161–78. doi: 10.2174/187152612800100189

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Karlsson M, Hara N, Morata S, Sjovall F, Kilbaugh T, Hansson MJ, et al. Diverse and tissue-specific mitochondrial respiratory response in a mouse model of sepsis-induced multiple organ failure. Shock. (2016) 45:404–10. doi: 10.1097/SHK.0000000000000525

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Zhao WY, Zhang L, Sui MX, Zhu YH, Zeng L. Protective effects of sirtuin 3 in a murine model of sepsis-induced acute kidney injury. Sci Rep. (2016) 6:33201. doi: 10.1038/srep33201

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Li S, Wu H, Han D, Ma S, Fan W, Wang Y, et al. A novel mechanism of mesenchymal stromal cell-mediated protection against sepsis: restricting inflammasome activation in macrophages by increasing mitophagy and decreasing mitochondrial ROS. Oxid Med Cell Longev. (2018) 2018:3537609. doi: 10.1155/2018/3537609

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Shen X, Han G, Li S, Song Y, Shen H, Zhai Y, et al. Association between the T6459C point mutation of the mitochondrial MT-CO1 gene and susceptibility to sepsis among Chinese Han people. J Cell Mol Med. (2018) 22:5257–64. doi: 10.1111/jcmm.13746

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Zhang Z, Xu X, Ma J, Wu J, Wang Y, Zhou R, et al. Gene deletion of Gabarap enhances Nlrp3 inflammasome-dependent inflammatory responses. J Immunol. (2013) 190:3517–24. doi: 10.4049/jimmunol.1202628

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Xu J, Chi F, Guo T, Punj V, Lee WN, French SW, et al. NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation. J Clin Invest. (2015) 125:1579–90. doi: 10.1172/JCI76468

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Kasahara E, Inoue M. Cross-talk between HPA-axis-increased glucocorticoids and mitochondrial stress determines immune responses and clinical manifestations of patients with sepsis. Redox Rep. (2015) 20:1–10. doi: 10.1179/1351000214Y.0000000107

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Maher K, Jeric Kokelj B, Butinar M, Mikhaylov G, Mancek-Keber M, Stoka V, et al. A role for stefin B (cystatin B) in inflammation and endotoxemia. J Biol Chem. (2014) 289:31736–50. doi: 10.1074/jbc.M114.609396

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Kokkinaki D, Hoffman M, Kalliora C, Kyriazis ID, Maning J, Lucchese AM, et al. Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy. J Mol Cell Cardiol. (2019) 127:232–45. doi: 10.1016/j.yjmcc.2018.12.016

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Gu J, Luo L, Wang Q, Yan S, Lin J, Li D, et al. Maresin 1 attenuates mitochondrial dysfunction through the ALX/cAMP/ROS pathway in the cecal ligation and puncture mouse model and sepsis patients. Lab Invest. (2018) 98:715–33. doi: 10.1038/s41374-018-0031-x

PubMed Abstract | CrossRef Full Text | Google Scholar